Penn Medicine Abramson Cancer Center


 

Penn Medicine Updates on the KEYNOTE-716 Trial: DMFS With Pembro vs. Placebo as Adjuvant Therapy in Stage IIB/C Melanoma

44 views
July 14, 2022
0 Comments
Login to view comments. Click here to Login
Updates in Oncology 2022 Philadelphia